Infection prevention for immunocompromised patients: A cross-translational multicentric survey of current organization in France - 29/02/24
, B. Wyplosz d, M. Baldeyrou b, C. Paris a, c, P. Tattevin b, C. Janssen efor the SPILF group “Vaccination et Prévention”
Highlights |
• | In France, access to infection prevention advice for immunocompromised patients is suboptimal. |
• | Only 30% of the physicians interviewed reported on-site access to dedicated consultations. |
• | Most were aware of nationwide guidelines for vaccination of immunocompromised patients. |
• | Guidelines covering all fields of infection prevention would be more than welcome. |
Abstract |
Objectives |
To evaluate current organization of infection prevention for immunocompromised patients (ICP) at a countrywide level.
Methods |
Nationwide cross-sectional multicenter study based on an online survey disseminated in 2022 to physicians invested with preventive healthcare missions.
Results |
A total of 341 physicians (96% graduates, 32% infectious disease specialists), participated in the survey, with a median age of 40 [35–51] years. On-site access to infection prevention consultations for ICP was reported by 30%, dedicated pre-travel consultations for ICPs by 29%, consultations for infection prevention in solid organ transplant candidates by 16% and return-to-work consultations for ICPs by 6%. Most participants (73%) were aware of nationwide vaccination guidelines for ICP, while 50% felt comfortable using them. Tools for infection prevention advice and ICP vaccination had been developed by 10%, while 89% would have appreciated access to tools developed by others.
Conclusions |
Infection prevention for ICPs remains neglected. Guidelines covering all fields of prevention for ICPs would be more than welcome.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Vaccination, Immunocompromised, Prevention, Infectious risk
Mappa
Vol 54 - N° 2
Articolo 104863- marzo 2024 Ritorno al numero
Articolo precedente
- Early picc-line infections in non-neutropenic patients are mainly due to E. coli suggesting that third-generation cephalosporin may be used as a first-line antibiotic therapy
- Victoria Volpari, Meghann Gallouche, Yvan Caspar, Anne Thiebaut-Bertrand, Olivier Épaulard, Patricia Pavese, Caroline Landelle, Marion Le Maréchal
- Integration of IgM ELISA and 56 kDa gene PCR in management of pediatric acute encephalitis syndrome associated with scrub typhus
- Pooja Bhardwaj, Vishal Yadav, Alok Sharma, Shahzadi Gulafshan, Sthita Pragnya Behera, Gaurav Raj Dwivedi, Hirawati Deval, Vijayachari Paluru, Manoj Murhekar, Rajeev Singh
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?